Lutein + zeaxanthin
Lutein + zeaxanthin has been studied in 38 papers since 2016: 5 trials and 24 observational studies in people, 7 reviews; 8 in the past year. Its furthest trials in people are at phase 3. The newest paper, Oct 26, 2026: “Associations Between Dietary Carotenoids and Cognitive Performance in Older Hispanic/Latino Adults are Stronger in Men and Smokers”.
2 new papers in 30 daysSee all 142 papers on lutein + zeaxanthin
At a glance
Independent labs found the same change in people. 14 independent labs in 4 countries; 5 trials, none about aging, 3 with no results posted.
“and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin.”
2 of its findings point the other way.
- 14 independent labs in 4 countries
- 2 findings against
- 5 trials, none about aging, 3 with no results posted
- Funders: National Institutes of Health and others
- 9 of 34 findings with company ties
- Human trial5
- Humans24
- In silico1
Studies in people
4 studies gave lutein + zeaxanthin to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on lung cancerOR 1.15 (95% CI, 0.79-1.66) down: Lowers the risk of age-related macular degenerationHR 0.91 (95% CI, 0.84-0.99) | Treated cohort10 years | 3,882 peopleBoth72.0 yearsOlder adults; 10-year follow-up | JAMA ophthalmology, Jun 3, 2022 |
up: Improves contrast sensitivity with glare0.147 and 0.149 LogMAR (p = 0.02 and 0.01) down: Decreases glare recovery time2.76 and 2.54 s (p = 0.008 and p = 0.02) up: Improves useful field of view divided attentionp < 0.001 | Randomized trialsix-month | 24 peopleBothelderlyOlder adults | Nutrients, Sep 14, 2021 |
| Randomized trial12 months | Both65-87 yearsOlder adults; in supplement responders with greater increases in MPOD, exploratory analysis | Journal of aging research, Dec 1, 2019 | |
up: Increases blood-oxygen-level dependent signal no change: Has no effect on cognitive functiond=.84 up: Increases macular pigment optical density | Randomized trial1 year | 44 people64–86 years of ageCommunity-dwelling older adults | Journal of the International Neuropsychological Society : JINS, Jul 11, 2017 |
What did studies of lutein + zeaxanthin find?
17Studies of lutein + zeaxanthin measured 17 outcomes; the most studied are macular pigment optical density (4 studies) and cognitive function (2).
Macular pigment optical density
upin humans3no changein humans1
4 studies
Macular pigment optical density
upin humans3no changein humans1
Lutein + zeaxanthin showed no clear effect on macular pigment optical density in humans (healthy participants).
“while no changes were noted in the LZ group.”
Human trialhealthy participantssupplementmacula6 mg lutein and 4 mg zeaxanthin, five times weekly90 days
Nutrients
Lutein + zeaxanthin increases macular pigment optical density in humans.
“The supplement group’s MPOD was significantly greater than the control group’s MPOD following the intervention [t(42)=2.44; p=.019], despite the two groups showing comparable MPOD at baseline (p >.05).”
Human trial1 yearn = 44
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial
Journal of the International Neuropsychological Society : JINS
Lutein + zeaxanthin increases macular pigment optical density in humans.
“Supplementation with lutein 10 mg and zeaxanthin 2 mg in AREDS 2 has been proven to increase MPOD”
ReviewAREDS 2 formulationmaculalutein 10 mg and zeaxanthin 2 mg
Cermin Dunia Kedokteran
Lutein + zeaxanthin increases macular pigment optical density in humans (populations with and without age-related macular degeneration) (Significant increases in 2 of 8 controlled studies).
“MPOD increased significantly in 2 of the 8 controlled studies.”
Reviewpopulations with and without age-related macular degenerationdietary interventionmacula
Nutrition reviews
Cognitive function
upin humans2no changein humans1+12%
2 studies
Cognitive function
upin humans2no changein humans1+12%
Lutein + zeaxanthin showed no clear effect on cognitive function in humans (d=.84).
“A mixed design ANOVA did not yield a statistically significant group (supplement vs. placebo) × time (baseline vs. post-intervention) interaction for number of words recalled within the scanner [F(1,42)=2.53; p=.119], although the effect size was large (d=.84).”
Human trial1 yearn = 44
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial
Journal of the International Neuropsychological Society : JINS
Lutein + zeaxanthin improves cognitive function in humans (community-dwelling) (Cohen's d=.84).
“L and Z appeared to buffer cognitive decline on the verbal learning task (Cohen's d=.84).”
Human trialcommunity-dwelling12 mg/daily1 yearn = 44
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial
Journal of the International Neuropsychological Society : JINS
Lutein + zeaxanthin improves cognitive function in humans (up to 12%).
“while in older adults, it boosts cognitive function by up to 12%.”
Review
International Journal of Innovative Technologies in Social Science
Blood-oxygen-level dependent signal
upin humans1
1 study
Blood-oxygen-level dependent signal
upin humans1
Lutein + zeaxanthin increases blood-oxygen-level dependent signal in humans.
“Following the encoding minus control contrast, significant group (supplement vs. placebo) × time (baseline vs. post-intervention) interactions were observed in left dorsolateral prefrontal cortex (F=21.34; p=.034, FWE-corrected, cluster size: 498 voxels) and anterior cingulate cortex (F=19.63; p=.028, FWE-corrected, cluster size: 146 voxels; see Figure 3”
Human trial1 yearn = 44
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial
Journal of the International Neuropsychological Society : JINS
Lutein + zeaxanthin increases blood-oxygen-level dependent signal in humans (community-dwelling) (p < .05).
“Significant interactions during learning were observed in left dorsolateral prefrontal cortex and anterior cingulate cortex (p < .05, family-wise-error corrected).”
Human trialcommunity-dwellingprefrontal cortex12 mg/daily1 yearn = 44
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial
Journal of the International Neuropsychological Society : JINS
Cognitive decline
downin humans1
1 study
Cognitive decline
downin humans1
Lutein + zeaxanthin is linked with less cognitive decline in humans (β = 0.020, 95% CI: 0.002-0.037).
“lutein + zeaxanthin (β = 0.020, 95% CI: 0.002-0.037)”
Humansn = 4,043
Health care science
Coronary artery disease
downin humans1
1 study
Coronary artery disease
downin humans1
Lutein + zeaxanthin is linked with less coronary artery disease in humans with accelerated aging.
“Both SHAP and LIME analyses consistently identified vitamin B12 and lutein + zeaxanthin as protective nutrients”
Humanswith accelerated aging
Frontiers in nutrition
Biological aging
downin humans1OR 0.93
1 study
Biological aging
downin humans1OR 0.93
Lutein + zeaxanthin is linked with lower biological aging in humans (OR 0.93, 95% CI 0.88–0.93, P = 0.016).
“Combined LZ intake is associated with attenuated multi-level biological aging [OR (95% CI): 0.93 (0.88, 0.93), P = 0.016]”
Humans
The association between lutein and zeaxanthin intake and multi-level biological aging
Frontiers in nutrition
Age-related macular degeneration
downin humans1
1 study
Age-related macular degeneration
downin humans1
Lutein + zeaxanthin protects against age-related macular degeneration in humans.
“leads to eye's protective functions of them including protection from age-related macular degeneration (AMD).”
Reviewmacula
Lutein and zeaxanthin - radio- and chemoprotective properties. Mechanism and possible use
Roczniki Panstwowego Zakladu Higieny
HDL cholesterol
upin humans1
1 study
HDL cholesterol
upin humans1
Lutein + zeaxanthin increases HDL cholesterol in humans (WMD: 4.06; 95% CI: 0.64, 7.48).
“L/Z treatment could significantly increase HDL-C levels in older adults (WMD: 4.06; 95% CI: 0.64, 7.48; I-square: 50.7%)”
Review
The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study
Prostaglandins & other lipid mediators
LDL cholesterol
no changein humans1
1 study
LDL cholesterol
no changein humans1
Lutein + zeaxanthin showed no clear effect on LDL cholesterol in humans (WMD: -4.54; 95% CI: -11.5, 2.48).
“L/Z supplementation has null effect on circulating levels of TC (WMD: -3.82 95% CI: -13.83, 6.18; I-square: 85.2%), and LDL-C (WMD: -4.54; 95% CI: -11.5, 2.48; I-square: 83.9%)”
Review
The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study
Prostaglandins & other lipid mediators
Total cholesterol
no changein humans1
1 study
Total cholesterol
no changein humans1
Lutein + zeaxanthin showed no clear effect on total cholesterol in humans (WMD: -3.82 95% CI: -13.83, 6.18).
“L/Z supplementation has null effect on circulating levels of TC (WMD: -3.82 95% CI: -13.83, 6.18; I-square: 85.2%)”
Review
The effect of lutein and Zeaxanthine on dyslipidemia: A meta-analysis study
Prostaglandins & other lipid mediators
Lung cancer
no changein humans1OR 1.15
1 study
Lung cancer
no changein humans1OR 1.15
Lutein + zeaxanthin showed no clear effect on lung cancer in humans (10-year follow-up) (OR 1.15 (95% CI, 0.79-1.66)).
“and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin.”
Human trial10-year follow-up10 yearsn = 3,882
JAMA ophthalmology
Skin carotenoids
no changein humans1
1 study
Skin carotenoids
no changein humans1
Lutein + zeaxanthin showed no clear effect on skin carotenoids in humans (healthy participants).
“Skin carotenoids were significantly increased in the goji berry group at day 45 (p = 0.025) and day 90 (p = 0.006), but not in the LZ group.”
Human trialhealthy participantssupplementskin6 mg lutein and 4 mg zeaxanthin, five times weekly45 and 90 days
Nutrients
Composite crash risk score
downin humans1
1 study
Composite crash risk score
downin humans1
Lutein + zeaxanthin decreases composite crash risk score in humans (p = 0.004).
“improved composite crash risk score (p = 0.004) were seen in the supplemented group.”
Human trialsix-monthn = 24
Nutrients
Useful field of view divided attention
upin humans1
1 study
Useful field of view divided attention
upin humans1
Lutein + zeaxanthin improves useful field of view divided attention in humans (p < 0.001).
“Improvements in UFOV scores of divided attention (p < 0.001) and improved composite crash risk score (p = 0.004) were seen in the supplemented group.”
Human trialsix-monthn = 24
Nutrients
Glare recovery time
downin humans1
1 study
Glare recovery time
downin humans1
Lutein + zeaxanthin decreases glare recovery time in humans (2.76 and 2.54 s (p = 0.008 and p = 0.02)).
“monocularly tested glare recovery time improved 2.76 and 2.54 s, respectively, (p = 0.008 and p = 0.02)”
Human trialeyesix-monthn = 24
Nutrients
All 17Fewer
What is lutein + zeaxanthin linked with?
12Studies link lutein + zeaxanthin with 12 measures, most often age-related macular degeneration (5 studies).
Age-related macular degeneration
downin humans5HR 0.91
5 studies
Age-related macular degeneration
downin humans5HR 0.91
Lutein + zeaxanthin lowers the risk of age-related macular degeneration in humans (comparing lutein/zeaxanthin with no lutein/zeaxanthin) (HR 0.91 (95% CI, 0.84-0.99)).
“The hazard ratio (HR) for progression to late AMD comparing lutein/zeaxanthin with no lutein/zeaxanthin was 0.91 (95% CI, 0.84-0.99; P = .02)”
Human trialcomparing lutein/zeaxanthin with no lutein/zeaxanthin10 yearsn = 3,882
JAMA ophthalmology
Lutein + zeaxanthin is linked with a lower risk of age-related macular degeneration in individuals with P. gingivalis-related AMD risk (by as much as 35% (P for interaction < 0.0001)).
“sustaining elevated serum levels of lutein/zeaxanthin (≥ 0.35 μmol/L or ≥ 20 μg/dL) might potentially mitigate the P. gingivalis-related AMD risk by as much as 35%”
Humansin individuals with P. gingivalis-related AMD risk≥ 0.35 μmol/L or ≥ 20 μg/dL
Scientific reports
Lutein + zeaxanthin is linked with a lower risk of age-related macular degeneration in humans (comparing the top and bottom tertiles) (OR 0.21, 95% CI 0.05-0.84).
“higher lutein/zeaxanthin content in plasma was significantly associated with a decreased risk of AMD, and the odds ratio (OR) comparing the top and bottom tertiles was 0.21 (95% CI: 0.05, 0.84”
Humanscomparing the top and bottom tertiles
Frontiers in nutrition
Lutein + zeaxanthin lowers the risk of age-related macular degeneration in humans (18–26%).
“Supplementation reduces the risk of AMD progression by 18–26%”
Review
International Journal of Innovative Technologies in Social Science
Lutein + zeaxanthin lowers the risk of age-related macular degeneration in older adults.
“high concentration of carotenoids such as lutein and zeaxanthin decrease the risk of developing age-related macular disease”
Reviewin older adults
Review of Evidence for the Usage of Antioxidants for Eye Aging
BioMed research international
Cognitive function
upin humans1
1 study
Cognitive function
upin humans1
Lutein + zeaxanthin is associated with cognitive function in humans (Hispanic/Latino adults) (β=0.21; p≤0.04).
“total carotenoids (β=0.26), α-carotene (β=0.22), β-cryptoxanthin (β=1.0), lutein+zeaxanthin (β=0.21), and lycopene (β=0.19) were significantly (all ps ≤ 0.04) associated with cognitive performance.”
HumansHispanic/Latino adults
The Journal of nutrition
Cataract
downin humans1
1 study
Cataract
downin humans1
Lutein + zeaxanthin lowers the risk of cataract in humans (20–25%).
“cortical cataracts by 20–25%”
Review
International Journal of Innovative Technologies in Social Science
Macular pigment optical volume
upin humans1
1 study
Macular pigment optical volume
upin humans1
Lutein + zeaxanthin is associated with macular pigment optical volume in humans (3-mm-diameter macula lutea in eAMD and iAMD) (r = 0.22-0.30, P < 0.01).
“weaker but significant for L&Z intake, and MPOV (r = 0.22-0.30, P < 0.01) of 3-mm-diameter macula lutea only, for eAMD and iAMD.”
Humans3-mm-diameter macula lutea in eAMD and iAMDretinan = 369
Investigative ophthalmology & visual science
Plasma lutein and zeaxanthin
upin humans1
1 study
Plasma lutein and zeaxanthin
upin humans1
Lutein + zeaxanthin is associated with plasma lutein and zeaxanthin in humans (total intake from diet and supplements) (Spearman r = 0.29-0.50, P < 0.01).
“moderate between total intake and plasma L&Z (Spearman r = 0.29-0.50, P < 0.01)”
Humanstotal intake from diet and supplementsplasman = 369
Investigative ophthalmology & visual science
Age-related macular degeneration progression
downin humans1
1 study
Age-related macular degeneration progression
downin humans1
Lutein + zeaxanthin lowers the risk of age-related macular degeneration progression in humans (age-related macular degeneration) (10%–26% reduction in progression risk).
“reduce the risk of progression of age-related macular degeneration (AMD) by 10%–26%.”
Reviewage-related macular degenerationAREDS 2 formulationmaculalutein 10 mg and zeaxanthin 2 mg
Cermin Dunia Kedokteran
Mortality
downin humans1
1 study
Mortality
downin humans1
Lutein + zeaxanthin is linked with a lower risk of mortality in humans (P < 0.001).
“high LZ intake significantly reduce the risk of all-cause death (P < 0.001)”
Humans
The association between lutein and zeaxanthin intake and multi-level biological aging
Frontiers in nutrition
Soluble Klotho
upin humans1
1 study
Soluble Klotho
upin humans1
Lutein + zeaxanthin is associated with soluble Klotho in humans.
“increased intake of α-carotene, β-carotene, and lutein with zeaxanthin was associated with elevated S-Klotho levels”
Humans
Frontiers in endocrinology
Osteoporosis
downin humans1OR 0.53
1 study
Osteoporosis
downin humans1OR 0.53
Lutein + zeaxanthin is linked with a lower risk of osteoporosis in humans (OR 0.53, 95% CI 0.30–0.94; quintile 5 versus 1; P for trend = 0.076).
“A very high intake of lutein + zeaxanthin was also associated with lower risk of osteoporosis.”
Humansquintile 5 versus quintile 1both; 57.5% females
Archives of osteoporosis
Retinal venule caliber
upin humans1
1 study
Retinal venule caliber
upin humans1
Lutein + zeaxanthin is associated with retinal venule caliber in humans (214.6 ± 2.2 μm vs. 207.5 ± 2.2 μm).
“higher serum L/Z (tertile 3 vs. 1) was positively associated with arteriole caliber (mean ± SE, 145.0 ± 1.4 μm vs. 140.8 ± 1.4 μm; P = 0.05) and venule caliber (214.6 ± 2.2 μm vs. 207.5 ± 2.2 μm; P = 0.03).”
Humansretinafemalesn = 390
Investigative ophthalmology & visual science
All 12Fewer
Has lutein + zeaxanthin been tested in people?
0 of 5 about agingYes: 5 trials and 24 observational studies in people have been published, and 5 trials are registered.
In trials
Phase 3Completed1 trial
Phase 2Terminated1 trial
Phase 2Completed1 trial
Phase 2Completed1 trial
Phase 2Completed1 trial
Phase 2Results posted1 trial
All 8Fewer
Stopped
NCT00596024TerminatedAlzheimer's disease
Lack of enrollment
Trial sponsors
Universidade Federal De São Paulo
1 trialPhase 318 people
Asociación para Evitar la Ceguera en México
1 trialPhase 270 people
1 trialPhase 261 people
Oregon Health & Science University
1 trialPhase 23 people